NDUFA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.843700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.529400E-01
Normal-vs-Stage2
1.252810E-01
Normal-vs-Stage3
6.237800E-01
Normal-vs-Stage4
2.537800E-01
Stage1-vs-Stage2
7.489000E-01
Stage1-vs-Stage3
9.758000E-01
Stage1-vs-Stage4
6.046600E-01
Stage2-vs-Stage3
8.258400E-01
Stage2-vs-Stage4
4.440400E-01
Stage3-vs-Stage4
7.695600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.703000E-01
Normal-vs-AfricanAmerican
9.664600E-01
Normal-vs-Asian
5.242300E-02
Caucasian-vs-AfricanAmerican
5.701800E-01
Caucasian-vs-Asian
1.006170E-01
AfricanAmerican-vs-Asian
5.796500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.363800E-02
Normal-vs-Female
5.784600E-01
Male-vs-Female
5.114600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.648800E-01
Normal-vs-Age(41-60Yrs)
8.238400E-01
Normal-vs-Age(61-80Yrs)
3.828100E-02
Normal-vs-Age(81-100Yrs)
3.500200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.103000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.092600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.616600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.154200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.554250E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.732000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.163800E-01
Normal-vs-Daily Drinker
3.883500E-02
Normal-vs-Weekly Drinker
1.781410E-01
Normal-vs-Occasional Drinker
3.453200E-01
Normal-vs-Social Drinker
9.478600E-01
Non Drinker-vs-Daily Drinker
6.107900E-02
Non Drinker-vs-Weekly Drinker
2.233800E-01
Non Drinker-vs-Occasional Drinker
1.032400E-01
Non Drinker-vs-Social Drinker
9.568800E-01
Daily Drinker-vs-Weekly Drinker
8.252800E-01
Daily Drinker-vs-Occasional Drinker
4.124800E-01
Daily Drinker-vs-Social Drinker
8.270000E-02
Weekly Drinker-vs-Occasional Drinker
6.891600E-01
Weekly Drinker-vs-Social Drinker
2.401400E-01
Occasional Drinker-vs-Social Drinker
1.696420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.270200E-01
Normal-vs-Grade 2
2.646200E-01
Normal-vs-Grade 3
4.086800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.317210E-01
Grade 1-vs-Grade 3
4.146400E-02
Grade 1-vs-Grade 4
3.270200E-01
Grade 2-vs-Grade 3
2.031200E-01
Grade 2-vs-Grade 4
2.646200E-01
Grade 3-vs-Grade 4
4.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.423400E-01
Normal-vs-NonDiabetic
1.485750E-02
Diabetic-vs-NonDiabetic
1.279640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.550400E-01
Normal-vs-NoPancreatitis
5.881000E-01
Pancreatitis-vs-NoPancreatitis
3.379600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.490600E-01
Normal-vs-N1
1.821790E-01
N0-vs-N1
1.647190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.904800E-01
Normal-vs-TP53-NonMutant
8.719200E-01
TP53-Mutant-vs-TP53-NonMutant
5.686400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
